FROM OUR EXPERTS
What is the right tool for 24/7 pain? Having the right tool for the job can mean the difference between being on a roller coaster of uncontrolled pain versus being on a merry-go-round of good pain control. Pain medications have two basic methods for delivering the active ingredient: immediate release or sustained release.
Immediate release medications are designed for occasional, temporary pain because they work fast but don't last. This allows a person to use these short-acting medications like Vicodin , Lortab , and Percocet "as needed for pain" (this is a common instruction on prescription bottles). However, many people end up using quick-acting medications constantly, around-the-clock for 24/7 pain. That is like trying to use a hammer as if it were a nail. Immediate release medications are the wrong tools for the job of controlling constant pain. Because these medications wear-off so quickly, one never has a chance to stay ahead of the pain. Instead, this roller coaster...
Myofascial Release Therapy is a treatment option that many people are not aware of. It is a hands-on type of therapy that is particularly effective for fibromyalgia, myofascial pain syndrome, and can be quite helpful for many other types of chronic pain as well. What It Is To understand what Myofascial Release Therapy is, it's important to know what fascia is. Fascia is the connective tissue that surrounds, supports and stabilizes every muscle, bone, organ, nerve, blood vessel and cell in the body. It forms a continuous web from head to toe. Think of a piece of raw chicken. Between the skin and the meat you'll find a layer of thin white tissue – that is the fascia. The fascia is normally fluid and moves easily, but when there is an injury, the fascia constricts to protect the injured area. Usually when the injury heals, the fascia relaxes and goes back to its normal state. However, sometimes it can get bound up and crea...
Earlier this month, the FDA's Anesthetic and Analgesic Drug Products Advisory Committee overwhelmingly voted against recommending approval of Zohydro ER, an extended-release version of hydrocodone. If approved, Zohydro ER would have been the first hydrocodone medication available that did not also contain a non-opioid analgesic such as acetaminophen or ibuprofen.
While the FDA does not have to follow the recommendation of its advisory committee, it usually does. The final determination is expected to be made by March 1, 2013.
Despite the fact that Zohydro ER was studied in nearly 1,500 patients––some for as long as a year––and found to be generally safe and well-tolerated with no new or unexpected safety problems, panel members expressed concerns with potential abuse, addiction and long-term safety.
It was noted that the manufacturer didn't offer any solution as to how they would limit unintended use other than the already tight distributio...
You should know
Answers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.